Silo Pharma’s $5.75 Million Public Offering and Nasdaq Uplisting

Sichenzia Ross Ference represented Laidlaw & Company (UK) Ltd. în the transaction while Sheppard Mullin advised Silo Pharma.Silo Pharma, Inc. (Nasdaq: SILO) announced the $5.75 million initial…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now